Table 1.
Sample characteristics.
| Characteristic | Mean ± SD |
| Age (years) | 76.9 ± 9.4 |
| Height (cm) | 156.7 ± 6.5 |
| Weight (kg) (n = 13)a | 53.1 ± 10 |
| Dementia history (months) | 49.4 ± 40.5 |
| Gender | Number of cases (%) |
| Male | 9 (28) |
| Female | 23 (72) |
| Total | 32 (100) |
| Medical history | Number of cases (%) |
| None | 21 (66) |
| Existing | 11 (34) |
| Total | 32 (100) |
| Diseaseb | |
| Hypertension | 1 |
| Hyperlipidemia | 1 |
| Glaucoma | 1 |
| Cholecystitis | 1 |
| Alcoholism | 1 |
| Cerebral infarction | 1 |
| Epidural hematoma | 1 |
| Lumbar compression fracture | 1 |
| Previous spinal canal stenosis surgery | 1 |
| Breast cancer | 1 |
| Previous breast cancer surgery | 1 |
| Previous stomach cancer surgery | 1 |
| Medical complications | Number of cases (%) |
| None | 16 (50) |
| Existing | 16 (50) |
| Total | 32 (100) |
| Complicationb | |
| Hypertension | 8 |
| Diabetes | 3 |
| Hyperlipidemia | 2 |
| Prostatic hypertrophy | 2 |
| Depressive state | 2 |
| Hyperuricemia | 1 |
| Chronic gastritis | 1 |
| Chronic nephritis | 1 |
| Primary osteoporosis | 1 |
| Hypothyroidism | 1 |
| Tension headache | 1 |
| Depression | 1 |
| Suspected Parkinsonism | 1 |
| Concomitant AD medication | Number of cases (%) |
| Yes | 25 (78) |
| No | 7 (22) |
| Total | 32 (100) |
| Concomitant ChEI medication | Number of cases (%) |
| None | 12 (38) |
| Existingc | 20 (62) |
| Total | 32 (100) |
| Medicationb | |
| Donepezil (5 mg) | 9 |
| Donepezil (10 mg) | 2 |
| Galantamine (8 mg) | 1 |
| Galantamine (16 mg) | 3 |
| Galantamine (24 mg) | 1 |
| Rivastigmine (18 mg) | 4 |
| Other concomitant medications for BPSD | Number of cases (%) |
| None | 22 (69) |
| Existing | 10 (31) |
| Total | 32 (100) |
| Medicationb | |
| Antipsychotic | 7 |
| Antidepressant | 5 |
| Antianxiety | 4 |
| Hypnotic | 1 |
a
Missing data = 19.
b
There are duplicate cases.
c
Administration period until start of study, 9.9 ± 9.7 months [n = 16].